SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-15-046370
Filing Date
2015-08-05
Accepted
2015-08-05 11:07:09
Documents
3
Period of Report
2015-07-30
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v417183_8k.htm 8-K 16296
2 PRESS RELEASE v417183_ex99-1.htm EX-99.1 104169
4 GRAPHIC header.jpg GRAPHIC 13160
  Complete submission text file 0001144204-15-046370.txt   139962
Mailing Address 5600 BLAZER PARKWAY SUITE 200 DUBLIN OH 43017
Business Address 5600 BLAZER PARKWAY SUITE 200 DUBLIN OH 43017 6147937500
NAVIDEA BIOPHARMACEUTICALS, INC. (Filer) CIK: 0000810509 (see all company filings)

IRS No.: 311080091 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35076 | Film No.: 151027908
SIC: 2835 In Vitro & In Vivo Diagnostic Substances